As of 31 Dec 2025, 15 institutional investors reported holding 999,605 shares of Estrella Immunopharma, Inc. - COM (ESLA).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 999,605 | $1,559,085 | +$479,373 | $1.56 | 15 |
| 2025 Q3 | 743,186 | $878,824 | +$136,305 | $1.15 | 13 |
| 2025 Q2 | 634,819 | $559,552 | +$21,644 | $0.96 | 11 |
| 2025 Q1 | 613,145 | $568,449 | +$294,571 | $0.93 | 11 |
| 2024 Q4 | 292,276 | $341,108 | +$108,454 | $1.20 | 11 |
| 2024 Q3 | 200,095 | $232,108 | +$69,208 | $1.16 | 10 |
| 2024 Q2 | 123,037 | $129,188 | -$16,862 | $1.05 | 7 |
| 2024 Q1 | 135,217 | $165,522 | +$8,208 | $1.24 | 6 |
| 2023 Q4 | 128,581 | $143,186 | +$143,186 | $1.11 | 7 |